PTAB Denies Coherus' Challenge To 2 Enbrel Patents
The Patent Trial and Appeal Board on Friday shot down Coherus BioSciences' request to reevaluate two patents owned by Hoffman-LaRoche Inc., which are licensed to Amgen Inc. for its blockbuster immunosuppressant...To view the full article, register now.
Already a subscriber? Click here to view full article